Cells and tissue interactions with glycated collagen and their relevance to delayed diabetic wound healing

被引:56
作者
Liao, Huijuan [1 ]
Zakhaleva, Julia [2 ]
Chen, Weiliam [1 ]
机构
[1] SUNY Stony Brook, Hlth Sci Ctr, Dept Biomed Engn, Stony Brook, NY 11794 USA
[2] SUNY Stony Brook, Hlth Sci Ctr, Sch Med, Stony Brook, NY 11794 USA
关键词
In vitro model; Collagen matrix; Glycation; Fibroblast; GLYCOSYLATED END-PRODUCTS; HUMAN DERMAL FIBROBLASTS; EXTRACELLULAR-MATRIX; GEL CONTRACTION; IN-VITRO; COMPLICATIONS; AMINOGUANIDINE; ENDPRODUCTS; PROTEINS; REPAIR;
D O I
10.1016/j.biomaterials.2008.11.038
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Dermal accumulation of advanced glycation end products (AGEs) has increasingly been implicated as the underlying cause of delayed diabetic wound healing. Devising an in vitro model to adequately mimic glycated tissues will facilitate investigation into the mechanism of glycation in conjunction with exploration of new approaches or improvement of current therapies for treating diabetic chronic wounds. Collagen matrices were artificially glycated and the presence of AGEs was demonstrated by immunostaining. Both the mechanical properties of the collagen matrices and their interactions with fibroblasts (morphology, attachment, proliferation, and migration) were altered after glycation, more there was evidence of impairment on extracellular matrix (ECM) remodeling as well as inhibition of cell-induced material contraction. The actin cytoskeletons of the fibroblasts residing in the glycated collagen matrices were reorganized. In vivo mice full-thickness dermal wound models implanted with glycated collagen matrices showed delayed wound healing response. Thus, the glycated collagen matrix is an adequate in vitro model to mimic glycated tissues and could serve as a facile experimental tool to investigate the mechanism of glycation in conjunction with exploration of new approaches or improvement of current therapies for treating diabetic wounds. Published by Elsevier Ltd.
引用
收藏
页码:1689 / 1696
页数:8
相关论文
共 42 条
[1]   N-epsilon-(carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins [J].
Ahmed, MU ;
Frye, EB ;
Degenhardt, TP ;
Thorpe, SR ;
Baynes, JW .
BIOCHEMICAL JOURNAL, 1997, 324 :565-570
[2]   Advanced glycation endproducts - role in pathology of diabetic complications [J].
Ahmed, N .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2005, 67 (01) :3-21
[3]   Advanced glycation end products enhance expression of pro-apoptotic genes and stimulate fibroblast apoptosis through cytoplasmic and mitochondrial pathways [J].
Alikhani, ZB ;
Alikhani, M ;
Boyd, CM ;
Nagao, K ;
Trackman, PC ;
Graves, DT .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (13) :12087-12095
[4]   PRODUCTION OF A TISSUE-LIKE STRUCTURE BY CONTRACTION OF COLLAGEN LATTICES BY HUMAN-FIBROBLASTS OF DIFFERENT PROLIFERATIVE POTENTIAL INVITRO [J].
BELL, E ;
IVARSSON, B ;
MERRILL, C .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1979, 76 (03) :1274-1278
[5]  
BERG JSV, 1995, AM J PATHOL, V146, P1273
[6]   The molecular biology of chronic wounds and delayed healing in diabetes [J].
Blakytny, R. ;
Jude, E. .
DIABETIC MEDICINE, 2006, 23 (06) :594-608
[7]   ADVANCED PROTEIN GLYCOSYLATION IN DIABETES AND AGING [J].
BROWNLEE, M .
ANNUAL REVIEW OF MEDICINE, 1995, 46 :223-234
[8]   EFFECTS OF AMINOGUANIDINE ON PERIPHERAL-NERVE FUNCTION AND POLYOL PATHWAY METABOLITES IN STREPTOZOTOCIN-DIABETIC RATS [J].
CAMERON, NE ;
COTTER, MA ;
DINES, K ;
LOVE, A .
DIABETOLOGIA, 1992, 35 (10) :946-950
[9]  
Chettibi S., 1999, INFLAMMATION BASIC P, P865
[10]   MODULATION OF FIBROBLASTIC CYTOSKELETAL FEATURES DURING PATHOLOGICAL SITUATIONS - THE ROLE OF EXTRACELLULAR-MATRIX AND CYTOKINES [J].
DESMOULIERE, A ;
GABBIANI, G .
CELL MOTILITY AND THE CYTOSKELETON, 1994, 29 (03) :195-203